EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.

Oncotarget · 2016 · PMC5342500 · PMID 27612429

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp = 3.6e-143actually significant

The overlap between the EPRS and ESR1 LINCS signatures is highly significant (corrected FET p = 3.6e-143, OR = 8.86) (Figure 6B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.